Dr Amarbalita Martin Joins Us

We are delighted to announce that Dr Amarbalita Martin has joined our team.

Amarbalita has global experience that spans Pharma, Biotech, Medical Devices and university spin outs, where she has helped build commercial teams, hire technical and scientific personnel and recruit functional teams in Discovery and R&D.

She began her career with a PhD from Warwick University, followed by two postdoctoral research posts specialising in Protein Biochemistry. After deciding to move into industry, she transitioned into clinical diagnostics and before assuming a commercial role at Biacore AB, now part of Cytiva. This was followed by a move to Gyros as the company’s first European scientist, helping to bring a new miniaturised microfluidic, Elisa-based technology to market, working closely with Pharma and Biotech across Europe.

Amarbalita’s industry experience led to a growing interest in the importance of expert individuals to life science companies and this ultimately led to her transition into executive search. She has worked on senior appointments in executive search since 2005 and is trusted for her exceptional people skills. Her deep industry knowledge and ability to rapidly interpret client business objectives benefits both clients and candidates alike.

Dafydd Wright, Managing Partner comments, “We are so pleased to welcome Amarbalita to the team. Amarbalita has a strong industry reputation and is appreciated by clients and candidates alike. Her scientific background, combined with her excellent understanding of cultural fit makes her an incredible asset to the recruitment process.”

“I am delighted to join SCi Partners,” comments Amarbalita Martin. ”SCi Partners is a growing force in our industry with an excellent cohort of experienced biotech and life science recruitment experts. I am looking foward to working alongside Dafydd and colleagues to bring new areas of expertise to the partnership.”

Stay Connected

More News...

Giant Health Event 2023

In a dynamic session at the GIANT Health Event, recognised by the Financial Times as “Europe’s largest, most valuable annual festival of health-tech innovation,” our